Effect of Interferon‐Gamma on the Expression of HLA‐DR by Human Melanoma Cells of Varying Metastatic Potential
- 1 September 1990
- journal article
- research article
- Published by Wiley in Pigment Cell Research
- Vol. 3 (3) , 162-167
- https://doi.org/10.1111/j.1600-0749.1990.tb00282.x
Abstract
Three human melanoma cell lines of varying invasive and metastatic potential were analyzed for their ability to express HLA‐DR antigens on the cell surface as well as transcriptionally at the mRNA level in the presence and absence of IFN‐γ treatment. Cells of low and intermediate metastatic and invasive potential showed a high percentage of HLA‐DR surface expression, both before (91.2‐99.9%) and after (97.8‐99.9%) IFN‐γ treatment, as quantitated by flow cytometry. In contrast, cells of high metastatic and invasive potential expressed barely detectable levels of HLA‐DR‐positive cells before IFN‐γ treatment (0.3‐0.6%) and displayed elevated levels following treatment (42.3‐89.4%(. Allowing the highly metastatic cells to recover for 7 or 14 days following IFN‐γ treatment resulted in barely detectable levels of HLA‐DR‐positive cells. Northern blot analyses of HLA‐DR transcription levels showed a strong expression in cells of low and intermediate metastatic and invasive potential. HLA‐DR mRNA levels were not detectable in control cells of high metastatic potential nor in those cells which had undergone 7‐ and 14‐day recovery periods following IFN‐γ treatment. There was, however, an induction of HLA‐DR expression in the cells that had been treated with IFN‐γ for 72 hr and allowed no recovery period. In addition, a punctate, receptor‐like pattern of immunofluorescence staining pattern for cell surface HLA‐DR was seen after a 72 hr IFN‐γ treatment in the highly metastatic cells. In contrast, cells of low and intermediate metastatic potential expressed a homogeneous ring‐like pattern of antigen expression.Keywords
This publication has 23 references indexed in Scilit:
- The role of major histocompatibility complex class I antigens in tumorigenesis: future applications in cancer therapyBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 1989
- in vivo effects of combination treatment with recombinant interferon‐gamma and ‐alpha in metastatic melanomaInternational Journal of Cancer, 1989
- Phenotypic expression of histocompatibility antigens in human primary tumours and metastasesClinical & Experimental Metastasis, 1989
- Recombinant gamma interferon and in vivo induction of HLA-DR antigensBritish Journal of Dermatology, 1988
- The rate of malignant melanoma in the United States: Are we making an impact?Journal of the American Academy of Dermatology, 1987
- Recombinant Interferon-γ Stimulates the Production of Human Tumor Necrosis FactorIn VitroJournal of Interferon Research, 1987
- Surface antigens of melanoma and melanocytes. Specificity of induction of Ia antigens by human gamma-interferon.The Journal of Experimental Medicine, 1984
- Isolation of biologically active ribonucleic acid from sources enriched in ribonucleaseBiochemistry, 1979
- DR (Ia-like) antigens on human melanoma cells. Serological detection and immunochemical characterization.The Journal of Experimental Medicine, 1979
- FUNCTION OF MACROPHAGES IN ANTIGEN RECOGNITION BY GUINEA PIG T LYMPHOCYTESThe Journal of Experimental Medicine, 1973